Anti-cancer therapy with EGFR inhibitors: factors of prognostic and predictive significance

Ann Oncol. 2006 Mar:17 Suppl 2:ii42-45. doi: 10.1093/annonc/mdj920.
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Colorectal Neoplasms / drug therapy
  • Enzyme Inhibitors / administration & dosage
  • ErbB Receptors / antagonists & inhibitors*
  • Glioma / drug therapy
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Medical Oncology
  • Prognosis

Substances

  • Antibodies, Monoclonal
  • Enzyme Inhibitors
  • ErbB Receptors